also on other fortune lists

company facts

f500 stats

Fortune 500

Daniel Acker — Bloomberg via Getty Images




Last year marked the end of an era for Pfizer. As the company’s patent exclusivity expired for Viagra, its blockbuster erectile dysfunction drug, the pharmaceutical giant has struggled to discover its next big hit. In January, Pfizer discontinued its research into treatments for Alzheimer’s and Parkinson’s. And after long resisting calls to split itself up, the company is now mulling whether to sell its consumer healthcare business to suitors such as Procter & Gamble. Meanwhile Pfizer, which acquired biosimilars maker Hospira in 2015, is still working to address that company’s manufacturing issues, which have led to drug shortages.

Looking for leads, investment insights, or competitive intelligence?


Albert Bourla

CEO Title

Chairman & Chief Executive Officer


Health Care



HQ Location

New York City

Years on Fortune 500 List




Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$52,546-0.5%
Profits ($M)$21,308.0195.3%
Assets ($M)$171,797
Total Stockholder Equity ($M)$71,308
Market Value — as of March 29, 2018 ($M)$211,115
Profit Ratios
Profit as % of Revenues40.6%
Profits as % of Assets12.4%
Profits as % of Stockholder Equity29.9%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)3.52
EPS % Change (from 2016)200.9%
EPS % Change (5 year annual rate)12.7%
EPS % Change (10 year annual rate)11.6%
Total Return
Total Return to Investors (2017)15.7%
Total Return to Investors (5 year, annualized)11.4%
Total Return to Investors (10 year, annualized)9.3%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Pfizer

With Brexit's Trade Future Unsure, British Companies Don't Keep Calm, They Stockpile On

“Nearly every square meter” of warehouse space is full, said Business Minister Richard Harrington.

Read More →
Drugmakers Celebrate the New Year by Raising Prices on Hundreds of Drugs an Average of 6.3%

The average price increase is nearly three times the current U.S. inflation rate.

Read More →
Glaxo to Split in Two Following Venture Deal with Pfizer

The pharma giants plan to create a consumer-health joint venture and list it on the stock market

Read More →